| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-71 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2012-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a15810f5d670c26f65f9758688ce26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_543283a6a2db0dea3cd0209537dbeea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c7d6598c00c60788e7ee8967fd940b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1cb7adefe73226c9bcda31604410098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8674d10eb361fa9cb06357a7e4f187bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_818c39f8f1f46e3cd649784d4d5399d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a92c74d0a5ac28bc57139a90342b586e |
| publicationDate |
2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DK-2755999-T3 |
| titleOfInvention |
ANTI-ALPHA BETA TCR ANTIBODY |
| abstract |
The present invention relates to humanized monoclonal antibodies comprising the CDRs of murine antibody BMA031, which bind to the apTCR.CD3 complex and possess improved biological properties. |
| priorityDate |
2011-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |